Lista de obras -

A dynamic model forecasting myocardial infarct size before, during, and after reperfusion therapy: an ASSENT-2 ECG/VCG substudy

artículo científico publicado en 2005

A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes

scientific article published on 12 September 2006

A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry.

artículo científico publicado en 2004

Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy

artículo científico publicado en 2004

Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparin

artículo científico publicado en 2012

Acute ST-segment elevation myocardial infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

artículo científico publicado en 2008

Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study

artículo científico publicado en 2004

Adverse outcomes in fibrinolytic-based facilitated percutaneous coronary intervention: insights from the ASSENT-4 PCI electrocardiographic substudy

artículo científico publicado en 2008

Alignment of site versus adjudication committee-based diagnosis with patient outcomes: Insights from the Providing Rapid Out of Hospital Acute Cardiovascular Treatment 3 trial

artículo científico publicado en 2015

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

article

An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary interventio

artículo científico publicado en 2018

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation

scientific article published on 17 March 2019

Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update

artículo científico publicado en 2016

Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial

scientific article published on 26 September 2019

Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

artículo científico publicado en 2008

Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights From the APPRAISE-2 Trial.

artículo científico publicado en 2015

Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial

artículo científico publicado en 2017

Apixaban with antiplatelet therapy after acute coronary syndrome

artículo científico publicado en 2011

Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.

artículo científico publicado en 2009

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

artículo científico publicado en 2022

Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial

artículo científico publicado en 2014

Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: insights from the Global Registry of Acute Coronary Events.

artículo científico publicado en 2010

Association of Clinical Factors and Therapeutic Strategies With Improvements in Survival Following Non-ST-Elevation Myocardial Infarction, 2003-2013. ⬇️

artículo científico publicado en 2016

Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial

artículo científico

Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial

Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal

artículo científico publicado en 2007

Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome

artículo científico publicado en 2015

Clinical characteristics and outcomes of acute coronary syndrome patients with left anterior hemiblock

artículo científico publicado en 2014

Clinical consequences of bleeding among individuals with a recent acute coronary syndrome: Insights from the APPRAISE-2 trial

artículo científico publicado en 2019

Comparative prognostic value of T-wave inversion and ST-segment depression on the admission electrocardiogram in non-ST-segment elevation acute coronary syndromes

artículo científico publicado en 2013

Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY).

artículo científico publicado en 2009

Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition

artículo científico publicado en 2015

Coordinated series of studies to evaluate characteristics and mechanisms of acute coronary syndromes in high-risk patients randomly assigned to enoxaparin or unfractionated heparin: design and rationale of the SYNERGY Library

artículo científico publicado en 2004

Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006

artículo científico publicado en 2007

Does 24-hour ST-segment resolution postfibrinolysis add prognostic value to a Q wave? An ASSENT 2 electrocardiographic substudy

artículo científico publicado en 2003

Does Management of Lipid Lowering Differ Between Specialists and Primary Care: Insights from GOAL Canada

artículo científico publicado en 2020

Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?

artículo científico publicado en 2007

Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial

artículo científico publicado en 2020

Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial

artículo científico publicado en 2014

Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

artículo científico publicado en 2019

Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview

artículo científico publicado en 2004

Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis

artículo científico publicado en 2007

Electrocardiographic Findings in Patients With Acute Coronary Syndrome Presenting With Out-of-Hospital Cardiac Arrest. ⬇️

artículo científico publicado en 2017

Electrocardiographic infarct size assessment after thrombolysis: insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trial

artículo científico publicado en 2005

Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial

artículo científico publicado en 2004

Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE registry)

article

Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation).

artículo científico publicado en 2013

Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocar

artículo científico publicado en 2008

Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarction ⬇️

artículo científico publicado en 2018

High-grade atrioventricular block in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events.

artículo científico publicado en 2014

High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial

artículo científico publicado en 2005

Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin: Insights From the AUGUSTUS Trial

artículo científico publicado en 2019

In-hospital switching between adenosine diphosphate receptor inhibitors in patients with acute myocardial infarction treated with percutaneous coronary intervention: Insights into contemporary practice from the TRANSLATE-ACS study

artículo científico publicado en 2014

Initial Invasive or Conservative Strategy for Stable Coronary Disease

scientific article published on 30 March 2020

Interprovincial Differences in Canadian Coronary Care Unit Resource Use and Outcomes.

artículo científico publicado en 2016

Intravenous platelet blockade with cangrelor during PCI.

artículo científico publicado en 2009

Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial

scientific article published on 15 October 2013

Left bundle branch block in non-ST-segment elevation acute coronary syndromes. Incidence, angiographic characteristics, and clinical outcomes.

artículo científico publicado en 2013

Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery

scientific article published on 21 June 2019

Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial

artículo científico publicado en 2020

Long-term outcomes associated with hospital acquired thrombocytopenia among patients with non-ST-segment elevation acute coronary syndrome

artículo científico publicado en 2014

Low-molecular-weight heparin compared with unfractionated heparin for patients with non-ST-segment elevation acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE initiative

artículo científico publicado en 2006

Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial

artículo científico publicado en 2014

Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trial

scientific article published in 2022

Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial

artículo científico publicado en 2008

Patient Onboarding and Engagement to Build a Digital Study After Enrollment in a Clinical Trial (TAILOR-PCI Digital Study): Intervention Study

artículo científico publicado en 2022

Performance of acute coronary syndrome approaches in Brazil. A report from the BRACE (Brazilian Registry in Acute Coronary syndromEs)

scientific article published on 10 August 2019

Platelet inhibition with cangrelor in patients undergoing PCI.

artículo científico publicado en 2009

Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI

scientific article published on 01 July 2020

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

artículo científico publicado en 2012

Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes

artículo científico

Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial

artículo científico publicado en 2008

Previous and New Onset Atrial Fibrillation and Associated Outcomes in Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events)

scientific article published on 21 June 2018

Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes—Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

article

Prognostic significance of electrocardiographic-determined left ventricular hypertrophy and associated ST-segment depression in patients with non-ST-elevation acute coronary syndromes.

artículo científico publicado en 2011

Prognostic significance of low QRS voltage on the admission electrocardiogram in acute coronary syndromes.

artículo científico publicado en 2015

Prognostic significance of presenting blood pressure in non-ST-segment elevation acute coronary syndrome in relation to prior history of hypertension.

artículo científico publicado en 2013

Pulse pressure in acute coronary syndromes: Comparative prognostic significance with systolic blood pressure

artículo científico publicado en 2017

Quantification of the effect of clopidogrel on enzymatic infarct size related to a percutaneous coronary intervention in patients with acute coronary syndromes: insights from the CHAMPION percutaneous coronary intervention trial

artículo científico publicado en 2013

Real-world risk of cardiovascular outcomes associated with hypertriglyceridaemia among individuals with atherosclerotic cardiovascular disease and potential eligibility for emerging therapies

artículo científico publicado en 2020

Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGY.

artículo científico publicado en 2009

Relationship of ST elevation in lead aVR with angiographic findings and outcome in non–ST elevation acute coronary syndromes

artículo científico publicado en 2007

ST resolution 1 hour after fibrinolysis for prediction of myocardial infarct size: insights from ASSENT 3.

artículo científico publicado en 2008

ST segment resolution in ASSENT 3: insights into the role of three different treatment strategies for acute myocardial infarction

artículo científico publicado en 2003

Short- and Long-Term Outcomes of Patients With Electrocardiographic Left Ventricular Hypertrophy After Fibrinolysis for Acute Myocardial Infarction

artículo científico publicado en 2005

Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events [GRACE]).

artículo científico publicado en 2004

Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome.

artículo científico publicado en 2008

Stent Thrombosis in Patients With Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial

scientific article published on 11 November 2019

Survival After Invasive or Conservative Management of Stable Coronary Disease

scientific article published in 2023

Temporal Trends of Women Enrollment in Major Cardiovascular Randomized Clinical Trials

scientific article published on 30 January 2019

Temporal trends in all-cause mortality according to smoking status: Insights from the Global Registry of Acute Coronary Events.

artículo científico publicado en 2016

The Risk / Benefit Tradeoff of Antithrombotic Therapy in Patients with Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights from AUGUSTUS

artículo científico publicado en 2020

The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE).

artículo científico publicado en 2006

The future of cardiovascular clinical research in North America and beyond-addressing challenges and leveraging opportunities through unique academic and grassroots collaborations

artículo científico

The impact of gender on the treatment and outcomes of patients with early reinfarction after fibrinolysis: insights from ASSENT-2⋆

artículo científico publicado en 2003

The impact of postrandomization crossover of therapy in acute coronary syndromes care

artículo científico

The prognostic value of the admission and predischarge electrocardiogram in acute coronary syndromes: The GUSTO-IIb ECG Core Laboratory experience

Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial

artículo científico publicado en 2019

Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: Rationale and design of the ticagrelor in patients with ST elevation myocardial infarction treated with thrombolysis (TREAT) trial

scientific article published on 03 March 2018

Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial.

artículo científico publicado en 2018

Time course of events in acute coronary syndromes: implications for clinical practice from the GRACE registry

artículo científico publicado en 2008

Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial

artículo científico publicado en 2007

Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trial

artículo científico publicado en 2007

Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go.

artículo científico publicado en 2008

Unraveling the spectrum of left bundle branch block in acute myocardial infarction: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT 2 and 3) trials

artículo científico publicado en 2006

Use of Clopidogrel Post-Coronary Artery Bypass Surgery in Canadian Patients With Acute Coronary Syndromes

article

Use of proven therapies in non–ST-elevation acute coronary syndromes according to evidence-based risk stratification

article

Lista de obras de

A dynamic model forecasting myocardial infarct size before, during, and after reperfusion therapy: an ASSENT-2 ECG/VCG substudy

A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes

A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry.

Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy

Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparin

Acute ST-segment elevation myocardial infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study

Adverse outcomes in fibrinolytic-based facilitated percutaneous coronary intervention: insights from the ASSENT-4 PCI electrocardiographic substudy

Alignment of site versus adjudication committee-based diagnosis with patient outcomes: Insights from the Providing Rapid Out of Hospital Acute Cardiovascular Treatment 3 trial

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary interventio

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation

Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update

Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial

Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights From the APPRAISE-2 Trial.

Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial

Apixaban with antiplatelet therapy after acute coronary syndrome

Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial

Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: insights from the Global Registry of Acute Coronary Events.

Association of Clinical Factors and Therapeutic Strategies With Improvements in Survival Following Non-ST-Elevation Myocardial Infarction, 2003-2013. ⬇️

Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial

Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial

Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal

Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome

Clinical characteristics and outcomes of acute coronary syndrome patients with left anterior hemiblock

Clinical consequences of bleeding among individuals with a recent acute coronary syndrome: Insights from the APPRAISE-2 trial

Comparative prognostic value of T-wave inversion and ST-segment depression on the admission electrocardiogram in non-ST-segment elevation acute coronary syndromes

Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY).

Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition

Coordinated series of studies to evaluate characteristics and mechanisms of acute coronary syndromes in high-risk patients randomly assigned to enoxaparin or unfractionated heparin: design and rationale of the SYNERGY Library

Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006

Does 24-hour ST-segment resolution postfibrinolysis add prognostic value to a Q wave? An ASSENT 2 electrocardiographic substudy

Does Management of Lipid Lowering Differ Between Specialists and Primary Care: Insights from GOAL Canada

Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?

Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial

Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial

Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview

Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis

Electrocardiographic Findings in Patients With Acute Coronary Syndrome Presenting With Out-of-Hospital Cardiac Arrest. ⬇️

Electrocardiographic infarct size assessment after thrombolysis: insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trial

Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial

Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE registry)

Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation).

Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocar

Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarction ⬇️

High-grade atrioventricular block in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events.

High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial

Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin: Insights From the AUGUSTUS Trial

In-hospital switching between adenosine diphosphate receptor inhibitors in patients with acute myocardial infarction treated with percutaneous coronary intervention: Insights into contemporary practice from the TRANSLATE-ACS study

Initial Invasive or Conservative Strategy for Stable Coronary Disease

Interprovincial Differences in Canadian Coronary Care Unit Resource Use and Outcomes.

Intravenous platelet blockade with cangrelor during PCI.

Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial

Left bundle branch block in non-ST-segment elevation acute coronary syndromes. Incidence, angiographic characteristics, and clinical outcomes.

Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery

Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial

Long-term outcomes associated with hospital acquired thrombocytopenia among patients with non-ST-segment elevation acute coronary syndrome

Low-molecular-weight heparin compared with unfractionated heparin for patients with non-ST-segment elevation acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE initiative

Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial

Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trial

Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial

Patient Onboarding and Engagement to Build a Digital Study After Enrollment in a Clinical Trial (TAILOR-PCI Digital Study): Intervention Study

Performance of acute coronary syndrome approaches in Brazil. A report from the BRACE (Brazilian Registry in Acute Coronary syndromEs)

Platelet inhibition with cangrelor in patients undergoing PCI.

Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes

Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial

Previous and New Onset Atrial Fibrillation and Associated Outcomes in Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events)

Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes—Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

Prognostic significance of electrocardiographic-determined left ventricular hypertrophy and associated ST-segment depression in patients with non-ST-elevation acute coronary syndromes.

Prognostic significance of low QRS voltage on the admission electrocardiogram in acute coronary syndromes.

Prognostic significance of presenting blood pressure in non-ST-segment elevation acute coronary syndrome in relation to prior history of hypertension.

Pulse pressure in acute coronary syndromes: Comparative prognostic significance with systolic blood pressure

Quantification of the effect of clopidogrel on enzymatic infarct size related to a percutaneous coronary intervention in patients with acute coronary syndromes: insights from the CHAMPION percutaneous coronary intervention trial